Erratum: Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer (Cancer DOI:10.1002/cncr.28784);Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer

Cancer

Volumn 120, Issue 17, 2014, Pages 2649-2656

  Helvie, Mark A ^a   Chang, Joanne T ^b   Hendrick, R Edward ^c   Banerjee, Mousumi ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

breast cancer; late stage disease; mammography; overdiagnosis; screening

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MIDDLE AGED; POPULATION RESEARCH; PRIORITY JOURNAL; TREND STUDY; TUMOR INVASION; UNITED STATES;

BREAST CANCER; LATE-STAGE DISEASE; MAMMOGRAPHY; OVERDIAGNOSIS; SCREENING;

ADULT; AGED; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DETECTION OF CANCER; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MAMMOGRAPHY; MIDDLE AGED; SEER PROGRAM; UNITED STATES;

EID: 84906789764     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28897     Document Type: Erratum

References (34)

1. Jemal A, Center MM, DeSantis C, Ward EM,. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010; 19: 1893-1907.
2. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L,; U.S. Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009; 151: 727-377, W237-W242.
3. Nickson C, Mason KE, English DR, Kavanagh AM,. Mammographic screening and breast cancer mortality: a case-control study and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012; 21: 1479-1488.
4. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009; 151: 738-747.
5. Fracheboud J, Otto SJ, van Dijck JA, Broeders MJ, Verbeek AL, de Koning HJ,; National Evaluation Team for Breast cancer screening (NETB). Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer. 2004; 91: 861-867.
6. Kricker A, Farac K, Smith D, Sweeny A, McCredie M, Armstrong BK,. Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening. Int J Cancer. 1999; 81: 877-880.
7. Foca F, Mancini S, Bucchi L, et al. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy. Cancer. 2013; 119: 2022-2028.
8. McCann J, Stockton D, Day N,. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Screen. 1998; 5: 42-48.
9. Schouten LJ, de Rijke JM, Schlangen JT, Verbeek AL,. Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, The Netherlands. J Med Screen. 1998; 5: 37-41.
10. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O,. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am. 1992; 30: 187-210.
11. Schootman M, Jeffe D, Reschke A, Aft R,. The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States. Breast Cancer Res Treat. 2004; 85: 219-222.
12. Anderson WF, Jatoi I, Devesa SS,. Assessing the impact of screening mammography: breast cancer incidence and mortality rates in Connecticut (1943-2002). Breast Cancer Res Treat. 2006; 99: 333-340.
13. Bleyer A, Welch HG,. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012; 367: 1998-2005.
14. Bray F, McCarron P, Parkin DM,. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004; 6: 229-239.
15. DeWaard F,. Recent time trends in breast cancer incidence. Prev Med. 1978; 7: 160-167.
16. Holford TR, Cronin KA, Mariotto AB, Feuer EJ,. Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr. 2006;(36): 19-25.
17. Stevens RG, Moolgavkar SH, Lee JA,. Temporal trends in breast cancer. Am J Epidemiol. 1982; 115: 759-777.
18. Miller BA, Feuer EJ, Hankey BF,. The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control. 1991; 2: 67-74.
19. Prior P, Woodman CB, Wilson S, Threlfall AG,. Reliability of underlying incidence rates for estimating the effect and efficiency of screening for breast cancer. J Med Screen. 1996; 3: 119-122.
20. Joensuu H, Toikkanen S,. Comparison of breast carcinomas diagnosed in the 1980s with those diagnosed in the 1940s to 1960s. BMJ. 1991; 303: 155-158.
21. Feuer EJ, Wun LM,. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol. 1992; 136: 1423-1436.
22. Garfinkel L, Boring CC, Heath CW Jr,. Changing trends. An overview of breast cancer incidence and mortality. Cancer. 1994; 74 (suppl 1): 222-227.
23. Leung GM, Thach TQ, Lam TH, et al. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. Br J Cancer. 2002; 87: 982-988.
24. Chokunonga E, Borok MZ, Chirenje ZM, Nyakabau AM, Parkin DM,. Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010. Int J Cancer. 2013; 133: 721-729.
25. National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program. SEER Data, 1973-2011 (Including July-December 2005 Hurricane Katrina Impacted Louisiana Cases). http://seer.cancer.gov/data/. Accessed September 20, 2013.
26. National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program. SEER Cancer Statistics Review (CSR) 1975-2010. http://seer.cancer.gov/csr/1975-2011. Accessed September 20, 2013.
27. Cancer Research UK. Breast Cancer Incidence Statistics: Trends of Time (Females). http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/ incidence/#trends. Accessed September 24, 2013.
28. Cancer Research UK. Breast Cancer Incidence Statistics. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/incidence/. Accessed August 7, 2013.
29. Etzioni R, Gulati R, Mallinger L, Mandelblatt J,. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med. 2013; 158: 831-838.
30. Puliti D, Duffy SW, Miccinesi G, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen. 2012; 19 (suppl 1): 42-56.
31. Johnson RH, Chien FL, Bleyer A,. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA. 2013; 309: 800-805.
32. Breen N, Kessler L,. Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview Surveys. Am J Public Health. 1994; 84: 62-67.
33. Cronin KA, Miglioretti DL, Krapcho M, et al. Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1699-1705.
34. Elkin EB, Hudis C, Begg CB, Schrag D,. The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999. Cancer. 2005; 104: 1149-1157.